Café

© 2026 Longbridge｜Terms of Service Privacy Policy

OCSAW

OCSAW

3.8300.00%( 0.000 )

LongbridgeAI

Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis | OCS Stock News

StockTitan

Mar 31, 2026 at 12:01 AM

Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis | OCS Stock News

Oculis Announces European Medicines Agency PRIME Designation for Privosegtor, Advancing a Potential First‑in‑Class Neuroprotective Candidate for Optic Neuritis | OCS Stock News

Login to unlock176characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Ocular Therap

USOCUL

+2.19%

Oculis Holding AG

USOCS

+0.38%

OCULIS HOLDING AG C/WTS 06/03/2028 (TO PUR ORD)

USOCSAW

0.00%